Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (212)	2/25/1999 1:24:00 AM
From: Miljenko Zuanic	Read Replies (2) \| Respond to of 3158

Peter: Are you still holding NXTR? Message 7995881 I am predicting acquisition of the NXTR general (maybe by Alza, as expansion of their drug delivery technology and after SEQU acquisition, still there are other possibility) before ITRX spit off (ops, it should be spin off), June 99. Acquisition price @~16-18 for NXTR-G, and ~3-5 for ITRX spin. <<The Iterex results are expected to be classified as discontinued operations and would include a charge of approximately $10 million related to the estimated net operating losses of the division for the first half of 1999. Whay will NXTR calculate and report 4Q results (with ~10MM ITRX losses in 99 calculated for 4Q 98???) without impact of the ITRX and 3Q ahead of the spin, while spin has to be confirmed by SH and is still in air? Miljenko